If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Directors' Dealing

7 May 2009 07:00

RNS Number : 8147R
Stanelco PLC
07 May 2009
 



7 May 2009 

 

Stanelco PLC ("Stanelco" or the "Company") 

 

Directors' Dealing 

 

Stanelco announces that on 30 April 2009 the Company issued a letter of wishes to the trustees of the Stanelco Plc Employee Benefit Trust (EBT) asking them to consider appointing 158,524,591 options over Stanelco plc Ordinary Shares of 0.1p each to sub trusts for the benefit of certain Directors and PDMRs of the Company, and their connected parties, as set out below.

 

In accordance with the Share Options Policy adopted by the Remuneration Committee the Options are issued with the following performance conditions. On the exercise date, if the share price of the Company's Ordinary 0.1p shares is equal to 1.0p then 25% of the options will become available for exercise. The proportion of options available will increase pro-rata up to 100% if the share price is 2.5p or greater.

 

The letter of wishes in respect of the Options to the trustees of the EBT asked them to consider appointing the Options to sub trusts for the benefit of:

Mr Paul Mines, his spouse, widow, children or stepchildren under the age of 18 years old (in respect of an option over 49,180,328 Ordinary Shares);

Ms Sue Bygrave, her spouse, widower, children or stepchildren under the age of 18 years old (in respect of an option over 48,360,656 Ordinary Shares);

Mr Paul Law, his spouse, widow, children or stepchildren under the age of 18 years old (in respect of an option over 28,688,525 Ordinary Shares); and

Mr Neil Martin, his spouse, widow, children or stepchildren under the age of 18 years old (in respect of an option over 32,295,082 Ordinary Shares), 

each of which are at an exercise price of 0.61 pence per Ordinary Share, lapsing 23 April 2019, representing an award equal to 200 per cent of salary in accordance with the Share Options Policy. 

 

On 6 May 2009 the grant of these Options was confirmed by the trustees of the EBT. 

 

Following this confirmation, the Company's Directors and PDMRs are interested in the following options over Ordinary Shares: 

Name

Date granted

Date exercisable

Date option lapses

Exercise price

No. of Ordinary Shares

Paul Mines

4 July 2007

28 April 2008

24 April 2009

4 July 2010

28 April 2011

24 April 2012

3 July 2017

27 April 2018

23 April 2019

0.52p

0.80p

0.61p

57,692,308

37,500,000

49,180,328

Sue Bygrave

24 April 2009

24 April 2012

23 April 2019

0.61p

48,360,656

Paul Law

28 April 2008

24 April 2009

28 April 2011

24 April 2012

27 April 2018

23 April 2019

0.80p

0.61p

20,600,000

28,688,525

Neil Martin

24 Sept 2008

24 April 2009

24 Sept 2011 

24 April 2012

23 Sept 2018

23 April 2019

0.43p

0.61p

44,186,046

32,295,082

For further information please contact: 

 

Donna Simpson, Company Secretary, Stanelco plc Tel: +44 (0)2380 867100 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSAFMFTMMMMBPL
Date   Source Headline
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.